Graham Capital Management »

Peregrine Pharmaceuticals shares owned by Graham Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $75k 11k 6.70
2023-12-31 $99k 15k 6.50

More positions owned by Graham Capital Management

Microstrategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 2/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Ishares Bitcoin Tr SHS
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Transocean Deb 4.000%12/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)
Dollar General (DG)
Green Plains Note 2.250% 3/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Peregrine Pharmaceuticals

BlackRock
Millennium Management
Vanguard Group
AltraVue Capital
12 West Capital Management
Royal Bank of Canada
Snyder Capital Management
Palisade Capital Management
Citadel Advisors
Point72 Asset Management
Newtyn Management
Wellington Management Company
Geode Capital Management
Morgan Stanley
Punch & Associates Investment Management

View all funds holding Peregrine Pharmaceuticals